TipRanks
Advertisement
Advertisement

AMGN Stock Latest News

Amgen price target raised to $400 from $380 at Barclays
The FlyAmgen price target raised to $400 from $380 at Barclays
11h ago
AMGN
AstraZeneca reports full results from Phase 3 CROSSING trial of Tezspire
PremiumThe Fly
AstraZeneca reports full results from Phase 3 CROSSING trial of Tezspire
1d ago
AZN
AMGN
AstraZeneca, Amgen announce TEZSPIRE showed ‘significant’ improvements
PremiumThe Fly
AstraZeneca, Amgen announce TEZSPIRE showed ‘significant’ improvements
1d ago
AZN
AMGN
Mattel appoints Griffith as Chief Financial Officer, Board Director
PremiumThe Fly
Mattel appoints Griffith as Chief Financial Officer, Board Director
2d ago
MAT
AMGN
Private Markets: TypeSafe AI, Oratomic secure fresh capital
PremiumThe Fly
Private Markets: TypeSafe AI, Oratomic secure fresh capital
6d ago
ZS
ABM
Amgen Fine-Tunes Evenity Delivery in New Phase 1 Study
PremiumCompany AnnouncementsAmgen Fine-Tunes Evenity Delivery in New Phase 1 Study
8d ago
AMGN
Amgen price target lowered to $378 from $388 at Guggenheim
Premium
The Fly
Amgen price target lowered to $378 from $388 at Guggenheim
8d ago
AMGN
Amgen price target lowered to $415 from $450 at BMO Capital
Premium
The Fly
Amgen price target lowered to $415 from $450 at BMO Capital
9d ago
AMGN
Amgen price target raised to $328 from $317 at BofA
PremiumThe Fly
Amgen price target raised to $328 from $317 at BofA
9d ago
AMGN
Amgen price target lowered to $430 from $435 at Wells Fargo
PremiumThe Fly
Amgen price target lowered to $430 from $435 at Wells Fargo
9d ago
AMGN
Amgen price target raised to $470 from $430 at UBS
PremiumThe Fly
Amgen price target raised to $470 from $430 at UBS
12d ago
AMGN
Amgen’s Monthly Diabetes Shot Takes Aim at Semaglutide in New Phase 3 Trial
PremiumCompany Announcements
Amgen’s Monthly Diabetes Shot Takes Aim at Semaglutide in New Phase 3 Trial
13d ago
AMGN
Amgen price target raised to $430 from $400 at RBC Capital
PremiumThe FlyAmgen price target raised to $430 from $400 at RBC Capital
13d ago
AMGN
Amgen price target raised to $440 from $400 at Cantor Fitzgerald
Premium
The Fly
Amgen price target raised to $440 from $400 at Cantor Fitzgerald
13d ago
AMGN
Former Gilead and Amgen Commercial Leader Laura Hamill Just Joined Entera (NASDAQ: ENTX)
Premium
TipRanks Newswire
Former Gilead and Amgen Commercial Leader Laura Hamill Just Joined Entera (NASDAQ: ENTX)
14d ago
LLY
AMGN
Early notable gainers among liquid option names on October 7th
PremiumThe Fly
Early notable gainers among liquid option names on October 7th
14d ago
KR
MPC
Amgen price target raised to $380 from $362 at Truist
PremiumThe Fly
Amgen price target raised to $380 from $362 at Truist
14d ago
AMGN
Amgen price target lowered to $359 from $362 at Morgan Stanley
PremiumThe Fly
Amgen price target lowered to $359 from $362 at Morgan Stanley
14d ago
AMGN
Amgen’s AMG 513 Obesity Trial Reaches Phase 1 Completion, Adding a New Angle to the Weight-Loss Drug Race
PremiumCompany Announcements
Amgen’s AMG 513 Obesity Trial Reaches Phase 1 Completion, Adding a New Angle to the Weight-Loss Drug Race
15d ago
AMGN
Amgen’s Evolocumab Study Signals Quiet Efficiency Gains for Cholesterol Franchise
PremiumCompany AnnouncementsAmgen’s Evolocumab Study Signals Quiet Efficiency Gains for Cholesterol Franchise
19d ago
AMGN
Amgen’s Pediatric Psoriasis Study in Japan Wraps Up, Setting the Stage for Otezla Growth
Premium
Company Announcements
Amgen’s Pediatric Psoriasis Study in Japan Wraps Up, Setting the Stage for Otezla Growth
20d ago
AMGN
Amgen price target raised to $500 from $450 at Scotiabank
Premium
The Fly
Amgen price target raised to $500 from $450 at Scotiabank
22d ago
AMGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >